Manufacturing and Analytical Characterization - Biomolecular
Yang Yang, PhD
Scientist II
AlexionPharmaceuticals, Inc.
New Haven, Connecticut, United States
Yang Yang, PhD
Scientist II
AlexionPharmaceuticals, Inc.
New Haven, Connecticut, United States
Jing Wu, Ph.D.
Scientist II
Alexion Pharmaceuticals, Inc.
New Haven, Connecticut, United States
Fang Wang, Ph.D.
Principal Scientist
Alexion Pharmaceuticals, Inc.
New Haven, Connecticut, United States
Mark Lefers, Ph.D.
Director
Alexion Pharmaceuticals, Inc.
New Haven, Connecticut, United States
The native digestion on the filter (NDF) experimental workflow for HCP identification includes filter-aided sample preparation and native digestion. During native digestion on the filter, mAbs remain intact due to disulfide bonds, while HCPs are cleaved into peptides. Subsequent centrifuge filtration separates the intact mAbs from the HCP peptides, facilitating HCP enrichment for comprehensive identification, regardless of peptide size.
The NDF experiment detects all six protein spikes, ranging from 12 kDa to 470 kDa at 1 ppm, with no bias towards smaller HCPs, allowing for an unbiased analysis. In contrast, ND only detects the Mb and Cyt c spikes, losing detection for larger proteins. At a 0.5 ppm spike level, NDF can still detect all spikes except the largest 470 kDa FN and provides nearly twice the unique peptide identification for Mb and Cyt c compared to ND, demonstrating a lower detection limit and offering greater identification confidence in the NDF method.
The Venn diagram of total HCPs identified in NISTmAb shows that NDF detects substantially more unique HCPs than ND.